Küleon is a drug discovery company leveraging proprietary, AI-based technology to identify novel serotonergic drugs for the targeted treatment of various neuropsychiatric diseases. We are advancing the understanding of serotonin receptor signaling in the brain to create target-directed approaches for treating diseases like schizophrenia and Alzheimer’s psychosis through novel mechanisms of action (MOAs). We have successful...
Küleon is a drug discovery company leveraging proprietary, AI-based technology to identify novel serotonergic drugs for the targeted treatment of various neuropsychiatric diseases. We are advancing the understanding of serotonin receptor signaling in the brain to create target-directed approaches for treating diseases like schizophrenia and Alzheimer’s psychosis through novel mechanisms of action (MOAs). We have successfully identified several preclinical leads that have significantly improved characteristics (biased signaling mechanism with limited hallucinogenic and cardiotoxic liability) when compared to other known serotonergic drugs.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.